Pterygium surgery using the principle of contact inhibition: results of 13 years’ experience by Tsutomu Hara et al.
CORNEA
Pterygium surgery using the principle of contact inhibition:
results of 13 years’ experience
Tsutomu Hara1 & Takako Hashimoto1 & Takeshi Hara1
Received: 22 August 2016 /Revised: 16 October 2016 /Accepted: 14 November 2016 /Published online: 28 November 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Purpose To report a technique to prevent pterygium recur-
rence using the principle of contact inhibition.
Methods Two hundred and fifteen patients (232 eyes; average
age, 64.1 years) with primary pterygia who underwent pteryg-
ium surgery at the Hara Eye Hospital between 1999 and 2012.
We retrospectively evaluated the patients who underwent the
following procedure to prevent pterygium recurrence. The
surface conjunctiva on the pterygium body was not removed.
After removing the pterygium body, by placing a narrow ped-
icle autoconjunctival flap along the corneal limbus and tying it
tightly to the front area of the residual conjunctiva, there is no
room for the active residual tissue to proliferate, thus
preventing a recurrence by contact inhibition. The key factor
is conjunctival suturing, which establishes face-to-face con-
tact of both areas of cut conjunctival tissue. Mitomycin C is
applied locally for 3 min intraoperatively and 5 days postop-
eratively. The main outcome measure was the prevention of
pterygium recurrence using this technique.
Results By the end of the average follow-up of 5 years
4 months, three eyes (1.3%) had a recurrence. Among the
232 eyes, 23 eyes had large pterygia extending to the pupillary
area. Using the surgical technique, there were no recurrences.
No specific characteristic of the recurrence was found in as-
sociation with the eye, sex, and preoperative grade.
Conclusions This surgery has three relevant features: (1) re-
confirmation of the effect of contact inhibition, (2) the ana-
tomic structure of the conjunctival sac scarcely changes post-
operatively, because the surface conjunctiva of the pterygium
body is not removed, and (3) a low recurrence rate.
Keywords Contact inhibition . Conjunctiva . Cornea .
Mitomycin . Pterygium
Introduction
In 1994, Hara and associates reported a new surgical tech-
nique for pterygium removal using the principle of contact
inhibition [1]. Contact inhibition is a critical mechanism that
regulates in-vitro and in-vivo cellular proliferation in a multi-
cellular component [2–4]. When a single cell is cultured, it
continues to grow; however, when the culture is filled with
cells, the cellular growth stops. The mechanism is the same
when two different cellular groups are cultured in one plate.
When the front lines of both groups meet, the growth of each
stops.
Many methods have been used to treat pterygia with dif-
fering results. In 2003, Hirst summarized the previous surger-
ies; his concept remains valid today [5], In 2013, Kaufman
et al. reported a new summary of cases from 2004 to 2011 in a
report by the American Academy of Ophthalmology [6].
Although there was no big change, the effect of mitomycin
C (MMC) is emphasized more in the latter. Generally, the
bared sclera technique was considered obsolete and the tech-
nique in which the bared sclera was covered by conjunctiva
became the standard. There were two types of coverings, one
covering only the defect and one to protect the limbal corneal
stem cells. An amnionic membrane graft was used in cases
with more progressed disease. But no one commented on our
Electronic supplementary material The online version of this article
(doi:10.1007/s00417-016-3558-9) contains supplementary material,
which is available to authorized users.
* Tsutomu Hara
office@haraganka.com
1 Hara Eye Hospital, 1-1-11 Nishi, Utsunomiya 320-0861, Japan
Graefes Arch Clin Exp Ophthalmol (2017) 255:583–590
DOI 10.1007/s00417-016-3558-9
1994 report on the use of the pedicle conjunctival flap with the
hypothesis of contact inhibition. Although it is a phenomenon
in cell biology and we had no fundamental proof, we specu-
lated that the concept might be useful in pterygium surgery.
Many reports of pterygium recurrence have been pub-
lished. With the bared scleral technique, the recurrence rates
have ranged from 11 to 61% [7–10]. When the conjunctival
defect was covered, the recurrence rates ranged from 0 to 10%
[9, 11–17]. Limbal conjunctival transplantation has been as-
sociated with recurrence rates ranging from 0 to 7.4% [15, 16,
18–20]. When a rotated conjunctival flap was transplanted,
3% of eyes had a recurrence [21]; with corneal limbal trans-
plantation of the corneal stem cells, 4.75% [22]; and with
amnionic membrane transplantation, 10.9% [15] and 25.0%
[23]. In 2011, Hirst reported that no pterygia recurred using
his technique, and the results of pterygium surgery have to be
defined by how the normal conjunctival condition is retained
[24].
However, with so many surgical procedures and different
results, the problem of recurrence is clearly unresolved.
Recognition of a universal surgical principle to apply to most
pterygium surgeries is required, which brought us to the im-
provement of our method in 1994.
In our previous report of contact inhibition, the recurrence
rate was 10.7% [1], which was still too high. However, during
the current 20-year trial, the key surgical factors were clarified
and we obtained markedly improved results. We speculated
that the principle of contact inhibition seems to be the funda-
mental factor in most pterygium surgeries. Many surgeons
believe that the technique used to treat primary pterygium is
insufficient for secondary pterygia. However, secondary pte-
rygia occur when the first pterygium surgery fails. Therefore,
establishing a successful technique to treat primary pterygia is
important.
Material and methods
Two hundred and fifteen patients (232 eyes) (74 men, 141
women; average age, 64.1 ± 12.0 years; range, 21–9 3 years)
were included who underwent pterygium surgery at the Hara
Eye Hospital between January 4, 1999 and December 29,
2012. All patients were consecutive and met three inclusion
criteria: one surgeon (Tsutomu Hara) performing all surgeries,
the presence of a primary pterygium, and a follow-up period
of at least 1 year (average follow-up period, 5 years 4 months
± 3 years 4 months; range, 1 year 0 month s–12 years
6 months). Among all subjects, 23 eyes of 23 patients (10
men, 13 women; average age, 64 years ± 9 years 3 months;
range, 49–83 years) had a giant pterygium with a head that
extended to the pupillary margin. Among these patients, the
average postoperative follow-up was 3 years 9 months
±2 years 5months (range, 1 year 0month–12years 6months).
The review board of the Hara Eye Hospital approved the study
protocol. After the patients received verbal and written expla-
nations of the surgery, each provided informed consent.
Surgical methods
To obtain excellent results with contact inhibition, the surgical
technique must be precisely performed. Sutures must be
placed to induce contact inhibition. All surgeries were per-
formed under a microscope. After instilling a drop of
oxybuproca ine hydroch lor ide (Benoxi l , San ten
Pharmaceutical, Osaka, Japan), a lid speculum was put in
place. Local anesthesia was induced with a subconjunctival
injection of 0.2 ml of 2% lidocaine hydrochloride (Xylocaine,
AstraZeneca, Osaka, Japan) including 0.0005% adrenaline
(Bosmin, Daiichi Sankyo, Tokyo, Japan).
Figure 1 shows the surgical steps. Figure 1-1 (surgeon’s
view) shows the basic surgical concept. The surface conjunc-
tiva is cut slightly from the corneal limbus (a-b) and both the
superior and inferior edges of the pterygium body (Fig. 1-2).
A conjunctival flap is created (Fig. 1-3). Sutures are placed to
mark each corner of the square conjunctival flap (a, b). After
the conjunctival cut, the thin conjunctiva generally shrinks
and the front portion shrinks inward. Rapid identification of
the exact cut edge of the front conjunctival flap becomes dif-
ficult. To obtain contact inhibition, exact face-to-face suturing
of the dissected tissue edges is indispensable. The marking
sutures are important, especially during the initial learning
period.
The pterygium body is resected maximally (Fig. 1-4). The
head of the pterygium in the cornea is removed grossly with
scissors or evulsion with forceps (Fig. 1-5). The residual tissue
in the cornea then is removed using an electric trephine. The
rotation speed should be as fast as possible and the strength of
grinding is determined by the grade of the drill touching the
cornea (Fig. 1-6).
A sponge soaked with 0.04%MMC (Kyowa Hakko Kirin,
Tokyo, Japan) is placed on the scleral surface and inner sur-
face of the conjunctival flap for 3 min (Fig. 1-7). The tissue is
then rinsed with 150 ml of lactated Ringer’s solution.
The pedicle autoconjunctival flap usually is created inferi-
orly considering the future possible surgeries for glaucoma
and cataract (Fig. 1-8, f-e-g). Making the pedicle flap (length
and width) correctly is important. The cut is performed care-
fully to avoid pulling the pedicle flap during cutting. If it is
pulled excessively, the final width of the pedicle flap becomes
narrower, and placing the subsequent sutures for inducing
contact inhibition becomes difficult. The length and width of
the pedicle flap are important. Even if the flap is short, it can
be sutured by pulling; but the width narrows, and suturing to
the remaining conjunctiva becomes difficult, resulting in in-
sufficient contact inhibition and possible pterygium
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recurrence. One millimeter should be added to the width of the
pterygium on the corneal limbus, which usually becomes the
optimal length of the conjunctival flap, usually 6 to 8 mm. If
the flap accidentally becomes free, it can be used as an isolated
flap and the surgery can be performed. The recommended
width of the pedicle flap (e, f) is usually about 0.8 to 1.0 mm.
Fig. 1 The surgical process. (surgeon’s view of the left eye.) 1 The initial
surgical plan. The dotted line indicates the planned incision site of the
surface conjunctiva. I, Pterygium body. II, Pedicle conjunctival flap. 2
Surgical process. Incision of the surface conjunctiva. 3 Knots are placed
at both corners of the conjunctival flap (a, b). The surface conjunctiva is
turned over. 4 The pterygium body is resected. 5 Gross removal of the
pterygium head with peeling or cut. 6, The corneal surface is smoothed
with an electric drill. 7A sponge is soaked with mitomycin C followed by
washing with Ringer’s solution. 8 Creation of a pedicle conjunctival flap.
Head of the pedicle conjunctival flap (e, f). Root of the pedicle flap (c, g).
9 The pedicle flap is rotated 90 degrees to the corneal limbus. The head of
the pedicle flap (e, f) is sutured. A needle is passed in the following order:
conjunctival flap, episclera, and conjunctiva. 10 The surface conjunctiva
(I) is returned to its original position. 11 Suturing of the surface
conjunctiva of the pterygium body. Suture a-g, b-e. Additional sutures
at the line of contact inhibition (e–g and a–b). Two to four sutures usually
are placed. 12 Final sutures are placed for the superior and inferior sides
of I. Two to three sutures usually are required for each side
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When rotating and fixing the pedicle flap, after a 90-degree
rotation (Fig. 1-9), the pedicle flap (c-f) is placed along the
corneal limbus. The inner side of the pedicle flap (c–f) should
be positioned exactly on the curved limbal line at the end of
surgery. This inner side (c–f) is not sutured. For exact place-
ment of subsequent sutures, bleeding should be cauterized.
Cautery to the corneal limbal sclera, which was used in almost
all cases, did not cause noticeable side-effects such as corneal
opacification, recurrence, or tissue necrosis. Exact fixation of
the pedicle flap is important. The apex of the pedicle flap (e, f)
generally is rounded due to the intraoperative contraction. It is
important to flatten it by scrubbing with forceps before sutur-
ing. At first, both sides of the pedicle flap (e, f) are sutured to
the opposite conjunctiva. The thin conjunctiva tends to contract
rapidly. If it is sutured only to the conjunctiva, it will soon cause
a postoperative wound defect and loss of contact inhibition.
Therefore, all sutures must be placed in this order: conjunctival
flap, episclera, and opposite conjunctiva (Fig. 1-9).
When suturing the pedicle flap and the surface conjunctiva
of the removed pterygium body (body conjunctiva) (Fig. 1-10),
the location of the marking sutures must be confirmed and then
the cut edges sutured face to face exactly as determined.
Seemingly compact suturing observed from above through
the operating microscope is not enough. The suturing must be
performed as described in this report (Fig. 2).
At the final suturing of the pedicle and body conjunctival
flaps (Fig. 1-11), the exact matching of both planes by meticu-
lous suturing induces contact inhibition. This is the most im-
portant part of the procedure. When the size and location are
prepared correctly, usually three to four sutures are required.
When suturing the upper and lower edges of the body con-
junctiva (Fig. 1-12), the body conjunctiva (I in Fig. 1-1) does
not extend further, but the conjunctiva on the outside area can
be shifted easily. Therefore, the site of needle penetration on the
episclera is determined at the body conjunctiva (I in Fig. 1-12).
Virgin silk (9–0) is preferable to nylon because of its greater
flexibility and reduced postoperative foreign-body sensation.
Slight irritation caused by the silk might induce more rapid
adherence of both tissues. The usual surgical time is about
40 min. If the inner side of the transplanted conjunctival flap
(c, f in Fig. 1-9) is inside the cornea, it should be resected until
the corneal limbus appears. While no recurrence develops from
this plane, patients may misunderstand it as the recurrence. A
video of this surgery is shown in Online Resource.
Postoperative treatment
The surgical eye is generally covered for 1 week. Sutures are
removed 2 weeks postoperatively. From 1 day postoperatively,
after lifting the eye cover 0.04% MMC eye drops are instilled
3 times a day for 5 days; 0.5% levofloxacin hydrate eye drops
(Cravit Ophthalmic Solution 0.5%, Santen Pharmaceutical) and
0.1% betamethasone sodium phosphate eye drops (Rinderon,
Shionogi Pharmaceutical, Osaka, Japan) are used six times daily
from 1 day preoperatively for 2 weeks. In addition, 0.1 ml of
0.38% dexamethasone sodium phosphate (Orgadrone, Daiichi
SankyoCo. Ltd.) is injected subconjunctivally three times during
the first postoperative week. Avasoconstrictor, 0.5% naphazolin
nitrate (Privina Ophthalmic Solution, Novartis Pharma, Tokyo,
Japan), is used for 3 months and then discontinued. Some con-
junctival hyperemia persists for at least 2 months but usually
fades by 3 months postoperatively.
Results
Recurrence
If even a small bit of tissue enters the inner side from the
corneal limbus during the follow-up, it is considered a recur-
rence. Of the 232 eyes, three (1.3%) eyes had a recurrence. We
Fig. 2 Face-to-face suturing. 1
Overview. 2–1 Side view of
correct face-to-face suturing to
induce contact inhibition
preventing proliferation. 2–2 Side
view of incorrect suturing. If a
correct face-to-face suturing is not
performed, proliferation occurs
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found no special relationship between the recurrence and the
preoperative appearance and size, age, sex, and grade of the
surgical treatment. All recurrences were small and needed no
additional surgery at the end of the follow-up period (Table 1).
No specific characteristic of the recurrence was found in as-
sociation with the eye, sex, and preoperative grade.
The pterygia recurred from the front line of the dissected
pterygium body (Fig. 1-2, a-b) in all three eyes; none occurred
from either the superior or inferior edges of the body conjunc-
tiva. Among the patients, 23 eyes had a giant pterygiumwith a
head reaching to the pupillary area, none of which recurred.
The preoperative and postoperative photographs of the 23
eyes with these giant pterygia are shown to prove the efficacy
of the procedure (Fig. 3, cases 1–23).
Complications
In one eye (no. 9) (Fig. 3-9), a corneal ulcer developed
2 months postoperatively. The patient had a history of herpetic
keratitis. The eye healed, leaving a well-covered ulcer. No
other complications such as tissue necrosis, restricted ocular
movement, cosmetic complaints, or ocular hypertension de-
veloped. In some eyes (Fig. 3-16, -18, -22, -23), mild corneal
opacification remained as a result of the pterygium depth.
Discussion
Use of a pedicle conjunctival flap is not new and used widely.
What is new is the concept of contact inhibition, although this
remains a hypothesis, as the key mechanism for preventing
postoperative recurrences of pterygium. We proposed the hy-
pothesis in 1994. The results were not optimal at the time, and
we modified some aspects of the previous surgical technique
to more effectively facilitate contact inhibition. The results
have improved greatly at present. However, some factors still
require discussion.
Key points of the current procedure
To facilitate contact inhibition, full contact must be established
at the end of surgery over the entire front line of the excised
pterygium body (Fig. 1-2, a-b). We suppose that the
chromosomal content of the G0 phase cells, which stop
regenerating after sensing tissue contact, should be the same
as in the diploid cells. If the cells sense that contact inhibition
has ceased, rapid cellular regeneration begins. Thus, tight con-
tact between the tissues at the end of the surgery is important.
Cases in which there was a recurrence, including those in
our previous report [1], were thought to have resulted from
insufficient contact inhibition, according to our long-term ex-
perience. The recurrences resulted from creation of a too short
or narrow pedicle flap or overlooking of both the turning
down of the front line of the cut conjunctiva or insufficient
suturing (Fig. 2). Incomplete contact caused further tissue
proliferation.
New finding of the current procedure
The pedicle flap was intentionally obtained from the area ex-
tremely close to the pterygium body (line c-f in Fig. 1-8).
Intraoperatively, it is left open toward the center of the cornea
without suturing (Fig. 1-9, 1-12), and no tissue regeneration
occurred from this line in any cases. The current study proved
that in the pterygium and conjunctiva only the line facing the
cornea (a–b in Fig. 1-2) has regenerative power. The wide area
of the conjunctiva including both the superior and inferior
sides had no regenerative power. In addition, the current use
of the pedicle flap resulted in almost no change in the anatom-
ic structure of the conjunctival sac.
Possible factors other than contact inhibition contributing
to good results
The first is the effect of MMC as emphasized in the 2013
American Academy of Ophthalmology report [6]. In 1983,
we evaluated the use of MMC applied to the postoperative
bared sclera. Without MMC, sometimes granuloma occurred,
and with high-dose MMC sometimes scleral necrosis oc-
curred [25]. In one eye (case 9) with a giant pterygium, a
temporal ulcer developed and healed later, leaving a slight
ulcer with a nubecula (Fig. 3-9). Many surgeons have used
steroids. Shimazaki and associates reported that steroids must
be used for an extended period and they prescribed steroids for
3 months [19]. We used a steroid eye drop for 2 weeks.
Table 1 Pterygium recurred in
three of 232 eyes Patient Sex Eye Age (years) Surgical date Surgery to
recurrence (months)
Follow-up (months)
TT Female Right 50 2000/3/2 2 47
YY Male Right 37 2004/4/9 2 94
WY Male Left 54 2007/4/13 21 21
No particular characteristics of the recurrences were identified
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Fig. 3 Twenty-three cases of giant pterygium that extend to the pupillary area. Pre-OP; preoperative finding, Post-OP; postoperative finding, Y = years;
Mos =months
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The future
The current study was limited by the absence of a control
group and extensive postoperative treatment. The important
finding was the low rate of recurrence of 1.3%. The next step
is to decrease or eliminate the postoperative medication. We
expect that 5 years more are needed before we have definitive
results. However, the current new findings, i.e., no need for
conjunctival resection of the pterygium body, recurrence site
limited to the front cut line of the conjunctiva, the simple
surgical technique leaving almost no postoperative changes
in the conjunctival structure, and reconfirmation of the effec-
tiveness of the hypothesis of contact inhibition, are useful for
future pterygium surgeries.
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